JP2021533166A5 - - Google Patents
Info
- Publication number
- JP2021533166A5 JP2021533166A5 JP2021506492A JP2021506492A JP2021533166A5 JP 2021533166 A5 JP2021533166 A5 JP 2021533166A5 JP 2021506492 A JP2021506492 A JP 2021506492A JP 2021506492 A JP2021506492 A JP 2021506492A JP 2021533166 A5 JP2021533166 A5 JP 2021533166A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- target ligand
- car
- payload drug
- drug
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862715666P | 2018-08-07 | 2018-08-07 | |
| US62/715,666 | 2018-08-07 | ||
| PCT/US2019/042726 WO2020033129A1 (en) | 2018-08-07 | 2019-07-21 | Rejuvenation of car t cell |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021533166A JP2021533166A (ja) | 2021-12-02 |
| JP2021533166A5 true JP2021533166A5 (https=) | 2022-07-28 |
| JPWO2020033129A5 JPWO2020033129A5 (https=) | 2022-07-28 |
| JP7623935B2 JP7623935B2 (ja) | 2025-01-29 |
Family
ID=69415080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506492A Active JP7623935B2 (ja) | 2018-08-07 | 2019-07-21 | Ｃａｒ ｔ細胞の若返り |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210308267A1 (https=) |
| EP (1) | EP3833400A4 (https=) |
| JP (1) | JP7623935B2 (https=) |
| KR (1) | KR20210042125A (https=) |
| CN (2) | CN112543651B (https=) |
| AU (1) | AU2019317278B2 (https=) |
| CA (1) | CA3108710A1 (https=) |
| SG (1) | SG11202100616VA (https=) |
| WO (1) | WO2020033129A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| JP7282521B2 (ja) | 2016-04-08 | 2023-05-29 | パーデュー・リサーチ・ファウンデイション | Ｃａｒ ｔ細胞療法のための方法および組成物 |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| JP7549303B2 (ja) | 2018-01-22 | 2024-09-11 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞の使用方法 |
| CN112105382A (zh) | 2018-02-23 | 2020-12-18 | 恩多塞特公司 | 用于car t细胞疗法的顺序方法 |
| CN112262214A (zh) | 2018-04-12 | 2021-01-22 | 优莫佳生物制药股份有限公司 | 病毒载体及包装细胞系 |
| AU2021217003A1 (en) | 2020-02-04 | 2022-09-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Anti-dinitrophenol chimeric antigen receptors |
| US20240058458A1 (en) * | 2020-03-06 | 2024-02-22 | Purdue Research Foundation | Methods, compounds, and compositions for modifying car-t cell activity |
| CN116096861A (zh) * | 2020-04-03 | 2023-05-09 | 赛立维公司 | 过继性细胞转移的增强 |
| US20240293456A1 (en) * | 2020-11-30 | 2024-09-05 | Purdue Research Foundation | Combinations of small molecule drug conjugate and car-expressing cytotoxic lymphocytes and methods of treating cancer using the same |
| US20240390505A1 (en) * | 2021-08-30 | 2024-11-28 | Purdue Research Foundation | Conjugates, compositions, and methods for rejuvenation of car t-cells |
| JP2025506652A (ja) * | 2022-02-18 | 2025-03-13 | エフ． ホフマン－ラ ロシュ アーゲー | 試料中の目的の分析物を検出するための方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8933197B2 (en) * | 2007-08-15 | 2015-01-13 | Amunix Operating Inc. | Compositions comprising modified biologically active polypeptides |
| KR102339240B1 (ko) * | 2013-10-15 | 2021-12-15 | 더 스크립스 리서치 인스티튜트 | 펩타이드 키메라 항원 수용체 t 세포 스위치 및 이의 용도 |
| EP3057991B8 (en) * | 2013-10-15 | 2019-09-04 | The Scripps Research Institute | Chimeric antigen receptor t cell switches and uses thereof |
| ES2918501T3 (es) * | 2013-12-19 | 2022-07-18 | Novartis Ag | Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos |
| WO2015092024A2 (en) * | 2013-12-20 | 2015-06-25 | Cellectis | Method of engineering multi-input signal sensitive t cell for immunotherapy |
| EP3593812A3 (en) * | 2014-03-15 | 2020-05-27 | Novartis AG | Treatment of cancer using chimeric antigen receptor |
| KR20160145802A (ko) * | 2014-04-23 | 2016-12-20 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 요법에 사용하기 위한 키메라 항원 수용체 (car) 및 이의 제조 방법 |
| US20180243340A1 (en) * | 2015-08-24 | 2018-08-30 | University Of Houston System | Combination therapy combining car + t cells with appropriately timed immunodulatory antibodies |
| CN109415687A (zh) * | 2016-04-07 | 2019-03-01 | 蓝鸟生物公司 | 嵌合抗原受体t细胞组合物 |
| JP7282521B2 (ja) * | 2016-04-08 | 2023-05-29 | パーデュー・リサーチ・ファウンデイション | Ｃａｒ ｔ細胞療法のための方法および組成物 |
| WO2017205661A1 (en) * | 2016-05-25 | 2017-11-30 | Purdue Research Foundation | Method of treating cancer by targeting myeloid-derived suppressor cells |
| CN116474108A (zh) * | 2016-12-14 | 2023-07-25 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)-靶向成像和治疗 |
| CN110662839A (zh) * | 2017-02-17 | 2020-01-07 | 珀杜研究基金会 | 用于细胞疗法的基于靶向性配体-有效负载的药物递送 |
-
2019
- 2019-07-21 KR KR1020217006445A patent/KR20210042125A/ko not_active Ceased
- 2019-07-21 WO PCT/US2019/042726 patent/WO2020033129A1/en not_active Ceased
- 2019-07-21 CN CN201980052586.7A patent/CN112543651B/zh active Active
- 2019-07-21 US US17/266,509 patent/US20210308267A1/en not_active Abandoned
- 2019-07-21 CA CA3108710A patent/CA3108710A1/en active Pending
- 2019-07-21 EP EP19847190.6A patent/EP3833400A4/en active Pending
- 2019-07-21 JP JP2021506492A patent/JP7623935B2/ja active Active
- 2019-07-21 SG SG11202100616VA patent/SG11202100616VA/en unknown
- 2019-07-21 CN CN202310525133.XA patent/CN116763943A/zh active Pending
- 2019-07-21 AU AU2019317278A patent/AU2019317278B2/en active Active
-
2023
- 2023-12-21 US US18/392,939 patent/US20240148880A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533166A5 (https=) | ||
| US11231419B2 (en) | Methods for detecting peptide/MHC/TCR binding | |
| Becker et al. | Biogenesis of mitochondria: dual role of Tom7 in modulating assembly of the preprotein translocase of the outer membrane | |
| Rubino et al. | Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes | |
| Ray et al. | Mechanism of active renal tubular efflux of tenofovir | |
| Che et al. | Inducing protein-protein interactions with molecular glues | |
| JP2017513524A5 (https=) | ||
| Malheiro et al. | Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation | |
| Seethala et al. | Handbook of drug screening | |
| Zeitler et al. | The FG-repeat asymmetry of the nuclear pore complex is dispensable for bulk nucleocytoplasmic transport in vivo | |
| Black et al. | NXT1 is necessary for the terminal step of Crm1-mediated nuclear export | |
| WO2005116072A3 (en) | Antibodies as t cell receptor mimics, methods of production and uses thereof | |
| WO2008054517A3 (en) | Immunosuppressant binding antibodies and methods of obtaining and using same | |
| JPWO2020033129A5 (https=) | ||
| JP2017514481A5 (https=) | ||
| JP2006502416A5 (https=) | ||
| Le Billan et al. | Corticosteroid receptors adopt distinct cyclical transcriptional signatures | |
| Glander et al. | Inosine 5′-monophosphate dehydrogenase activity as a biomarker in the field of transplantation | |
| Schnell | Shedding light on the chloroplast protein import machinery | |
| Aukrust et al. | Post‐translational modifications of Annexin A2 are linked to its association with perinuclear nonpolysomal mRNP complexes | |
| Adam et al. | Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis | |
| Giri et al. | CXCL12‐induced partitioning of flotillin‐1 with lipid rafts plays a role in CXCR4 function | |
| EP2180323A1 (en) | Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin A complexes in a blood sample | |
| US6410340B1 (en) | Use of an 8.4 kDa protein as an immunophilin reagent in protein binding assays for immunosuppressive drugs | |
| Dirscherl et al. | A two-hybrid antibody micropattern assay reveals specific in cis interactions of MHC I heavy chains at the cell surface |